Symbols / CAI $20.50 -1.58% Caris Life Sciences, Inc.

Healthcare • Biotechnology • United States • NMS
CAI Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 5.79B Enterprise Value 5.42B Income -537.96M Sales 812.03M Book/sh 2.04 Cash/sh 2.83
Dividend Yield — Payout 0.00% Employees 1846 IPO — P/E — Forward P/E 54.88
PEG — P/S 7.13 P/B 10.03 P/C — EV/EBITDA 80.06 EV/Sales 6.68
Quick Ratio 7.16 Current Ratio 7.85 Debt/Eq 74.08 LT Debt/Eq — EPS (ttm) -3.22 EPS next Y 0.37
EPS Growth — Revenue Growth 125.40% Earnings 2026-05-07 ROA 3.84% ROE -45.37% ROIC —
Gross Margin 66.63% Oper. Margin 30.19% Profit Margin -8.39% Shs Outstand 282.58M Shs Float 97.08M Short Float 7.05%
Short Ratio 3.78 Short Interest — 52W High 42.50 52W Low 16.28 Beta — Avg Volume 2.42M
Volume 1.29M Target Price $29.69 Recom Strong_buy Prev Close $20.83 Price $20.50 Change -1.58%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$3.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest CAI news

No recent news from Yahoo. Try the RSS feed for latest CAI news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-06 SPETZLER DAVID BAXLEY PH.D. President — 83,162 $0.00 $0
2026-03-06 HALBERT DAVID D Chief Executive Officer — 320,112 $0.00 $0
2026-03-06 BRILLE BRIAN J. Officer and Director — 83,162 $0.00 $0
2026-03-06 DENTON JOHN RUSSEL General Counsel — 63,971 $0.00 $0
2026-03-06 POWER LUKE THOMAS Chief Financial Officer — 63,971 $0.00 $0
2026-02-26 FREDRICKSON DAVID PAUL Director — 2,492 $20.06 $49,990
2026-02-26 CASTLEMAN PETER M Director — 5,509 $20.06 $110,511
2026-02-26 VACIRCA JEFF L Director — 2,492 $20.06 $49,990
2026-02-26 MINOR LLOYD B. Director — 2,492 $20.06 $49,990
2026-02-26 HALBERT JON S. Director — 2,492 $20.06 $49,990
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category